224 related articles for article (PubMed ID: 21480679)
1. Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration.
Gordon AJ; Kavanagh G; Krumm M; Ramgopal R; Paidisetty S; Aghevli M; Goodman F; Trafton J; Liberto J
Psychol Addict Behav; 2011 Jun; 25(2):215-24. PubMed ID: 21480679
[TBL] [Abstract][Full Text] [Related]
2. Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors.
Oliva EM; Harris AH; Trafton JA; Gordon AJ
Drug Alcohol Depend; 2012 May; 122(3):241-6. PubMed ID: 22115887
[TBL] [Abstract][Full Text] [Related]
3. Implementation of buprenorphine in the Veterans Health Administration: results of the first 3 years.
Gordon AJ; Trafton JA; Saxon AJ; Gifford AL; Goodman F; Calabrese VS; McNicholas L; Liberto J;
Drug Alcohol Depend; 2007 Oct; 90(2-3):292-6. PubMed ID: 17493771
[TBL] [Abstract][Full Text] [Related]
4. Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand?
Oliva EM; Trafton JA; Harris AH; Gordon AJ
Am J Drug Alcohol Abuse; 2013 Mar; 39(2):103-7. PubMed ID: 23421571
[TBL] [Abstract][Full Text] [Related]
5. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
Turner BJ; Laine C; Lin YT; Lynch K
Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
[TBL] [Abstract][Full Text] [Related]
6. The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone.
Stein BD; Gordon AJ; Sorbero M; Dick AW; Schuster J; Farmer C
Drug Alcohol Depend; 2012 Jun; 123(1-3):72-8. PubMed ID: 22093488
[TBL] [Abstract][Full Text] [Related]
7. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital.
Cunningham CO; Sohler NL; McCoy K; Kunins HV
Fam Med; 2006 May; 38(5):336-40. PubMed ID: 16673195
[TBL] [Abstract][Full Text] [Related]
8. Clinic-based treatment for opioid dependence: a qualitative inquiry.
McMurphy S; Shea J; Switzer J; Turner BJ
Am J Health Behav; 2006; 30(5):544-54. PubMed ID: 16893317
[TBL] [Abstract][Full Text] [Related]
9. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
[TBL] [Abstract][Full Text] [Related]
10. Comparison of costs and utilization among buprenorphine and methadone patients.
Barnett PG
Addiction; 2009 Jun; 104(6):982-92. PubMed ID: 19466922
[TBL] [Abstract][Full Text] [Related]
11. Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.
Molfenter T; Sherbeck C; Zehner M; Quanbeck A; McCarty D; Kim JS; Starr S
Subst Abuse Treat Prev Policy; 2015 Mar; 10():13. PubMed ID: 25884206
[TBL] [Abstract][Full Text] [Related]
12. Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs.
Finlay AK; Wong JJ; Ellerbe LS; Rubinsky A; Gupta S; Bowe TR; Schmidt EM; Timko C; Burden JL; Harris AHS
J Stud Alcohol Drugs; 2018 Nov; 79(6):909-917. PubMed ID: 30573022
[TBL] [Abstract][Full Text] [Related]
13. Consensus statement on office-based treatment of opioid dependence using buprenorphine.
Fiellin DA; Kleber H; Trumble-Hejduk JG; McLellan AT; Kosten TR
J Subst Abuse Treat; 2004 Sep; 27(2):153-9. PubMed ID: 15450648
[TBL] [Abstract][Full Text] [Related]
14. Managing opioid addiction with buprenorphine.
Donaher PA; Welsh C
Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
[TBL] [Abstract][Full Text] [Related]
15. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.
Hagedorn H; Kenny M; Gordon AJ; Ackland PE; Noorbaloochi S; Yu W; Harris AHS
Addict Sci Clin Pract; 2018 Dec; 13(1):25. PubMed ID: 30545409
[TBL] [Abstract][Full Text] [Related]
16. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
[TBL] [Abstract][Full Text] [Related]
17. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence.
Kissin W; McLeod C; Sonnefeld J; Stanton A
J Addict Dis; 2006; 25(4):91-103. PubMed ID: 17088229
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration.
Gordon AJ; Liberto J; Granda S; Salmon-Cox S; Andree T; McNicholas L
Am J Addict; 2008; 17(6):459-62. PubMed ID: 19034736
[TBL] [Abstract][Full Text] [Related]
19. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians.
Arfken CL; Johanson CE; di Menza S; Schuster CR
J Subst Abuse Treat; 2010 Sep; 39(2):96-104. PubMed ID: 20598829
[TBL] [Abstract][Full Text] [Related]
20. A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.
Taylor EN; Timko C; Binswanger IA; Harris AHS; Stimmel M; Smelson D; Finlay AK
Subst Abus; 2022; 43(1):556-563. PubMed ID: 34586978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
